Recombinant MMP9 (Andecaliximab Biosimilar) antibody
This Human Chimeric antibody specifically detects MMP9 (Andecaliximab Biosimilar) in ELISA and WB. It exhibits reactivity toward Human.
Catalog No. ABIN7538066
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant MMP9 (Andecaliximab Biosimilar) antibody (ABIN7538066)
Target
MMP9 (Andecaliximab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human, Mouse
Clonality
Chimeric
Conjugate
This MMP9 (Andecaliximab Biosimilar) antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Andecaliximab Biosimilar - Anti-MMP9 mAb - Research Grade
-
Characteristics
- Antibody Type: IgG4-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgG4
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- MMP9 (Andecaliximab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Andecaliximab is a recombinant chimeric IgG4 monoclonal antibody (mAb) targets matrix metalloproteinase 9 (MMP9). Andecaliximab shows the antifibrotic efficacy in idiopathic pulmonary fibrosis mouse models. Andecaliximab can be used for the research of gastric adenocarcinoma and idiopathic pulmonary fibrosis (IPF).
-
CAS-No
- 1518996-49-0
Target
-
You are here:
